Expanded Indication for Multiple Myeloma Drug in Renal Patients
Millennium Pharmaceuticals, Inc., of Cambridge, Mass., received an expanded indication for Velcade (bortezomib) for injection, without dose adjustments, in patients with impaired kidney function, including those needing dialysis.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.